269 related articles for article (PubMed ID: 17287218)
1. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
[TBL] [Abstract][Full Text] [Related]
2. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
3. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
Beirowski B; Weber M; Gross O
J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
[TBL] [Abstract][Full Text] [Related]
4. Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688.
Gross O; Koepke ML; Beirowski B; Schulze-Lohoff E; Segerer S; Weber M
Kidney Int; 2005 Aug; 68(2):456-63. PubMed ID: 16014022
[TBL] [Abstract][Full Text] [Related]
5. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
6. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
[TBL] [Abstract][Full Text] [Related]
7. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome.
Bae EH; Fang F; Williams VR; Konvalinka A; Zhou X; Patel VB; Song X; John R; Oudit GY; Pei Y; Scholey JW
Kidney Int; 2017 Jun; 91(6):1347-1361. PubMed ID: 28249676
[TBL] [Abstract][Full Text] [Related]
8. Complement C5 mediates experimental tubulointerstitial fibrosis.
Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
[TBL] [Abstract][Full Text] [Related]
10. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
[TBL] [Abstract][Full Text] [Related]
11. Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis.
Gross O; Girgert R; Rubel D; Temme J; Theissen S; Müller GA
Am J Hypertens; 2011 Mar; 24(3):355-61. PubMed ID: 21127470
[TBL] [Abstract][Full Text] [Related]
12. Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy.
Clauss S; Gross O; Kulkarni O; Avila-Ferrufino A; Radomska E; Segerer S; Eulberg D; Klussmann S; Anders HJ
J Pathol; 2009 May; 218(1):40-7. PubMed ID: 19156777
[TBL] [Abstract][Full Text] [Related]
13. The plant pathogenesis related protein GLIPR-2 is highly expressed in fibrotic kidney and promotes epithelial to mesenchymal transition in vitro.
Baxter RM; Crowell TP; George JA; Getman ME; Gardner H
Matrix Biol; 2007 Jan; 26(1):20-9. PubMed ID: 17055234
[TBL] [Abstract][Full Text] [Related]
14. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
16. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
[TBL] [Abstract][Full Text] [Related]
17. Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome.
Lu W; Phillips CL; Killen PD; Hlaing T; Harrison WR; Elder FF; Miner JH; Overbeek PA; Meisler MH
Genomics; 1999 Oct; 61(2):113-24. PubMed ID: 10534397
[TBL] [Abstract][Full Text] [Related]
18. Albumin contributes to kidney disease progression in Alport syndrome.
Jarad G; Knutsen RH; Mecham RP; Miner JH
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F120-30. PubMed ID: 27147675
[TBL] [Abstract][Full Text] [Related]
19. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
Krag S; Nyengaard JR; Wogensen L
Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
